NYSE · TDOC
Healthcare · Medical - Healthcare Information Services
$6.30
Up+$0.02 (+0.32%)
Updated Sep 20, 2026, 4:05 AM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
TDOC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning TDOC.
TDOC research
Company profile and research snapshot.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 3, 2026 | Citigroup | Neutral | — |
| Jul 30, 2026 | Canaccord Genuity | Buy | — |
| Jul 30, 2026 | Evercore ISI Group | In-Line | — |
| Jul 21, 2026 | Canaccord Genuity | Buy | — |
| Jul 7, 2026 | B of A Securities | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 31, 2026
Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC),
Benzinga · Jul 23, 2026
Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of careMultidisciplinary care teams, paired with always-on AI
Benzinga · Jul 21, 2026
Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and raises the price target from $10 to $11.
Benzinga · Mar 4, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning TDOC.
